# Press Releases

Public Relations: [DNAnexus Press](mailto:)

May 19, 2026

New

### [DNAnexus Scales AI-Driven Capabilities](/content/press/dnanexus-scales-ai-driven-capabilities/index.html)

17-Year Multiomics Pioneer Powers Next Era of Precision Health

[Read More](/content/press/dnanexus-scales-ai-driven-capabilities/index.html)

May 07, 2026

### [DNAnexus Wins MedTech Breakthrough’s PharmaTech Innovation Award](/content/press/dnanexus-wins-medtech-breakthroughs-pharmatech-innovation-award/index.html)

Enterprise Leading Orchestration Platform Honored for AI-Enabled Infrastructure and Next-Gen Digital Health & Medical Technology

[Read More](/content/press/dnanexus-wins-medtech-breakthroughs-pharmatech-innovation-award/index.html)

May 07, 2026

### [Longitude Prize on ALS Announces Stage 1 Discovery Award Winners](https://als.longitudeprize.org/discovery-award-teams)

Meet the Discovery Awardees of the Longitude Prize on ALS, awarded £100,000 each, as well as access to the Prize datasets and a technical support package to drive their computational work. These 20 pioneering, global and multidisciplinary teams are using cutting-edge AI to unlock the complexity of ALS.

[Read More](https://als.longitudeprize.org/discovery-award-teams)

November 10, 2025

### [EpiCypher Launches CUTANA® Cloud, a Powerful Epigenomic Data Analysis Platform](/content/press/epicypher-launches-cutana-cloud/index.html)

EpiCypher’s new bioinformatics platform, powered by DNAnexus, accelerates data analysis for leading chromatin mapping technologies including CUT&RUN and CUT&Tag.

[Read More](/content/press/epicypher-launches-cutana-cloud/index.html)

October 22, 2025

### [DNAnexus Honored with Frost & Sullivan’s 2025 Technology Innovation Leadership Award](/content/press/frost-sullivans-2025-technology-innovation-leadership-award?utm_campaign=Frost%20%26%20Sullivan%20Award&utm_content=352575891&utm_medium=social&utm_source=linkedin&hss_channel=lcp-912957/index.html)

DNAnexus earned recognition from Frost & Sullivan for its leadership in precision health informatics. The award highlights its groundbreaking platform for integrating complex clinical, multi-omics, and real-world data to deliver secure, actionable insights.

[Read More](/content/press/frost-sullivans-2025-technology-innovation-leadership-award?utm_campaign=Frost%20%26%20Sullivan%20Award&utm_content=352575891&utm_medium=social&utm_source=linkedin&hss_channel=lcp-912957/index.html)

September 11, 2025

### [DNAnexus and Oracle Join Forces to Deliver Genomic Insights at the Point of Care](/content/press/dnanexus-oracle-genomics-point-of-care/index.html)

Collaboration to enable healthcare professionals to access and interpret genomic data alongside patient medical history within Oracle Health EHR.

[Read More](/content/press/dnanexus-oracle-genomics-point-of-care/index.html)

August 27, 2025

### [DNAnexus Enhances Leadership to Fuel AI Innovation and Biopharma Expansion](/content/press/enhances-leadership-to-fuel-ai-innovation-and-biopharma-expansion/index.html)

Company appoints Pieter De Leenheer as Chief Technology Officer and Todd Oakland as Senior Vice President and General Manager of Biopharma Business Dx/Rx

[Read More](/content/press/enhances-leadership-to-fuel-ai-innovation-and-biopharma-expansion/index.html)

August 14, 2025

### [DNAnexus & Boehringer Ingelheim Named 2025 Prix Galien USA Nominee in Best Digital Health Solution for Project PRISM/Project CRYPTx](https://www.prnewswire.com/news-releases/the-galien-foundation-announces-2025-prix-galien-usa-nominees-for-best-digital-health-solution-best-medical-technology-incubators-accelerators-and-equity-and-best-startup-302529091.html)

This recognition highlights an emerging model for dynamic, cloud-based regulatory collaboration.

[Read More](https://www.prnewswire.com/news-releases/the-galien-foundation-announces-2025-prix-galien-usa-nominees-for-best-digital-health-solution-best-medical-technology-incubators-accelerators-and-equity-and-best-startup-302529091.html)

June 25, 2025

### [£7.5 million Longitude Prize on ALS launches](https://www.prnewswire.com/news-releases/7-5-million-longitude-prize-on-als-launches-302486976.html)

The Longitude Prize on ALS, a £7.5 million global challenge prize, has launched to incentivise and reward cutting edge AI-based approaches to transform drug discovery for the treatment of ALS (amyotrophic lateral sclerosis), the most common form of MND (motor neurone disease).

[Read More](https://www.prnewswire.com/news-releases/7-5-million-longitude-prize-on-als-launches-302486976.html)

May 20, 2025

### [ARPA-H pioneers game-changing cancer care designed to adapt throughout treatment](https://arpa-h.gov/news-and-events/arpa-h-pioneers-game-changing-cancer-care-designed-adapt-throughout-treatment)

Selected performer teams will use predictive models to match treatments with changing tumor biology and prevent disease progression.

[Read More](https://arpa-h.gov/news-and-events/arpa-h-pioneers-game-changing-cancer-care-designed-adapt-throughout-treatment)

May 01, 2025

### [Latin-American genetic data available securely to approved researchers worldwide](https://www.ndph.ox.ac.uk/news/latin-american-genetic-data-available-securely-to-approved-researchers-worldwide)

Genetic data from the largest blood-based prospective study of a Latin-American population are now available securely to academic researchers worldwide through the DNAnexus Trusted Research Environment (TRE).

[Read More](https://www.ndph.ox.ac.uk/news/latin-american-genetic-data-available-securely-to-approved-researchers-worldwide)

March 24, 2025

### [DNAnexus Announces Collaboration with AlidaBio to Enhance RNA Modification and Expression Analysis](/content/press/dnanexus-collaboration-alidabio/index.html)

AlidaBio EpiPlex™ customers now have cloud access to the EpiScout™ analysis software on DNAnexus’ secure, scalable precision health data cloud platform

[Read More](/content/press/dnanexus-collaboration-alidabio/index.html)

February 03, 2025

### [DNAnexus Expands Relationship with Veeva to Advance Global Regulatory Collaboration](/content/press/dnanexus-and-dnanexus-partners-with-veeva/index.html)

Companies come together to connect sponsors, agencies, and standards development organizations on a regulatory collaboration cloud

[Read More](/content/press/dnanexus-and-dnanexus-partners-with-veeva/index.html)

December 18, 2024

### [DNAnexus Recognized by Frost & Sullivan for Ability to Integrate and Synchronize Diverse Clinical and Multi-omics Data](https://www.prnewswire.com/news-releases/dnanexus-recognized-by-frost--sullivan-for-ability-to-integrate-and-synchronize-diverse-clinical-and-multi-omics-data-302334757.html?tc=eml_cleartime)

[Frost & Sullivan](https://c212.net/c/link/?t=0&l=en&o=4327229-1&h=314373660&u=http%3A%2F%2Fwww.frost.com%2F&a=Frost+%26+Sullivan) researched the bioinformatics-based drug discovery and development industry, and based on its analysis results, today recognized DNAnexus, provider of the leading enterprise platform for precision health data, with the 2024 Global Enabling Technology Leadership Award in the "bioinformatics-based drug discovery and development industry" category.

[Read More](https://www.prnewswire.com/news-releases/dnanexus-recognized-by-frost--sullivan-for-ability-to-integrate-and-synchronize-diverse-clinical-and-multi-omics-data-302334757.html?tc=eml_cleartime)

December 09, 2024

### [DNAnexus and Panomics Join Forces to Deliver Comprehensive, Interactive Multi-omics Data Solutions for Biopharma Organizations](/content/press/dnanexus-and-panomics-join-forces-to-deliver-comprehensive-interactive-multi-omics-data-solutions-for-biopharma-organizations/index.html)

Researchers can conduct large-scale transcriptomics and proteomics data analyses on secure, cloud-based platform to accelerate biomarker discovery and drug repurposing applications.

[Read More](/content/press/dnanexus-and-panomics-join-forces-to-deliver-comprehensive-interactive-multi-omics-data-solutions-for-biopharma-organizations/index.html)